Utilization of L5-S1 interbody cage in adult spinal deformity patients undergoing lumbar spinal osteotomies and spinopelvic fixation: A retrospective comparative study

成人脊柱畸形患者行腰椎截骨术和脊柱骨盆固定术时应用L5-S1椎间融合器:一项回顾性比较研究

阅读:2

Abstract

BACKGROUND: Adult spinal deformity (ASD) surgeries often face complications, such as pseudoarthrosis and rod fractures (RFs), particularly at the lumbosacral junction. While transforaminal lumbosacral interbody fusion (TLIF) at L5-S1 is thought to improve outcomes, its efficacy in major ASD surgeries remains unclear. This study aims to compare clinical and radiological outcomes and implant complications in patients undergoing spinopelvic fixation with or without L5-S1 TLIF. METHODS: A retrospective cohort study was conducted, including 157 ASD patients who underwent high-grade osteotomies and spinopelvic fixation from 2021 to 2024. Patients were divided into two groups: those with L5-S1 TLIF (C group, n = 71) and those without (NC group, n = 86). Outcomes included rod fracture (RF) rate, sagittal alignment, and patient-reported measures such as the Visual Analog Scale (VAS), Oswestry disability index (ODI), and 36-Item Short Form Survey (SF-36), assessed at baseline, 1, 6, and 12 months postoperatively. RESULTS: RFs were significantly lower in the C group (4% vs. 13%, P = 0.03). Improved postoperative sagittal vertical axis and pelvic tilt were noted in the C group (P < 0.01). Both VAS and ODI scores were significantly better at 6 and 12 months in the C group (P < 0.01), along with higher SF-36 scores. No significant differences in baseline characteristics, estimated blood loss, or operation time were observed. CONCLUSION: The use of L5-S1 TLIF reduces RF rates, improves sagittal alignment, and clinical outcomes in ASD surgery. Incorporating TLIF at L5-S1 may optimize outcomes without increasing perioperative risks.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。